HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HealthCentral.com IPO Expects Estimated $68 Mil. In Proceeds

This article was originally published in The Tan Sheet

Executive Summary

HealthCentral.com, an online health care content and e-commerce company, expects to generate $68.3 mil. from its upcoming initial public offering of 7.5 mil. shares for $9-$11 per share. The estimate is based on a price of $10 per share. The firm has applied to be traded on Nasdaq under the symbol "HCEN."

You may also be interested in...



HealthCentral.com Expands Supplement Presence With Vitamins.com Buy

HealthCentral.com's purchase of Vitamins.com expands the online healthcare content provider's dietary supplement/natural product offerings to more than 8,000. HealthCentral.com plans to issue $103.5 mil. in stock to Vitamins.com as part of the agreement.

Internet Healthcare Self-Regulatory Advertising Policy Planned By March

HiEthics, an alliance of 16 online health care information companies with Web sites claiming 27% of the total Internet audience, is working on a self-regulation code of conduct for advertising, sponsorship and content, with a consensus document hoped for by March 2000.

Rx.com Web Site Offers More Than 3,000 Non-Rx Health Care Items

Joining the burgeoning health segment of the Internet, Austin, Tex.-based Rx.com offers over 3,000 branded OTC, vitamin, herbal and other health care products with 1,200 products added each week. Privately held Rx.com will feature online prescription medication services in the next few months along with health care information, medical news, drug interaction updates and 24-hour access to pharmacists via e-mail or telephone.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel